Krsnaa Diagnostics Limited

BSE: KRSNAA543328ISIN INE08LI01020

Healthcare
Healthcare Service Provider
BSE 1000

Share price

₹482.90-2.70 (-0.56%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹846.55
52W low: ₹462.10
Off 52W high: -42.96%
1M return: -13.65%
3M return: -13.71%
6M return: -20.85%
1Y return: -37.25%
20D avg volume: 4,595
50 DMA: ₹538.24
200 DMA: ₹579.73

Key ratios Consolidated

Market cap: ₹1,566 Cr
Current price: ₹482.90
52W high / low: ₹846.55 / ₹462.10
Face value: ₹5.00
P/E: 15.97
P/B: 1.51
EPS (TTM): ₹30.24
Book value / share: ₹320.19
ROE: —
ROCE: 10.60%
Operating margin: —
Net margin: —
Debt / equity: 0.54
Net debt: ₹504.09 Cr
Interest cover: 4.80
Dividend yield: 0.41%
Dividend / share (TTM): ₹2.00
Payout: 6.61%
Cash conversion cycle: 122.3 days

Financials

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24
Income statement
	270.97	235.53	192.60	181.20	205.99	192.98	186.08	174.51	186.34	170.23	166.28	158.32
	6.16	7.24	31.50	3.77	4.17	3.95	4.39	9.24	4.59	7.32	4.34	4.08
	277.12	242.77	224.10	184.97	210.16	196.93	190.46	183.75	190.93	177.55	170.62	162.40
	244.36	220.34	172.40	165.20	178.61	169.51	161.86	158.27	165.53	154.35	148.02	146.31
	55.80	50.19	44.37	39.10	48.15	47.43	41.55	39.90	44.91	42.90	42.99	34.36
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—
	37.04	36.06	33.35	36.17	35.40	35.56	32.78	35.86	35.05	33.08	32.45	29.65
	15.45	14.83	12.08	7.79	8.19	6.30	6.81	6.13	6.39	5.32	7.32	4.14
	29.06	27.95	22.59	22.66	23.59	21.63	21.95	22.70	22.20	21.47	18.12	21.23
	107.00	91.31	60.00	59.49	63.29	58.59	58.77	40.10	39.62	39.24	37.71	38.52
	32.76	22.43	51.71	19.77	31.55	27.41	28.61	25.48	25.40	23.20	22.61	16.09
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	32.76	22.43	51.71	19.77	31.55	27.41	28.61	25.48	25.40	23.20	22.61	16.09
	8.18	5.88	9.98	4.44	7.62	6.90	7.93	6.06	5.81	5.28	3.88	3.12
	24.59	16.55	41.72	15.25	23.95	20.52	20.68	19.41	19.60	17.92	18.73	12.97
	7.64	5.10	12.86	4.72	7.38	6.35	6.40	6.01	6.07	5.55	5.80	4.09
Key metrics
	77.27	65.21	86.38	50.22	63.33	55.34	57.37	54.31	53.99	49.99	48.05	41.46
	28.50%	27.70%	44.80%	27.70%	30.70%	28.70%	30.80%	31.10%	29.00%	29.40%	28.90%	26.20%
	9.10%	7.00%	21.70%	8.40%	11.60%	10.60%	11.10%	11.10%	10.50%	10.50%	11.30%	8.20%
	3.00%	—	4.10%	—	3.60%	—	3.60%	—	—	—	—	—
	31.50%	22.00%	3.50%	3.80%	10.50%	13.40%	11.90%	10.20%	—	—	—	—
	2.70%	-19.30%	101.70%	-21.40%	22.20%	14.50%	10.40%	49.70%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22
Income statement
	880.30	772.77	717.16	619.63	487.12	455.45
	48.67	43.39	25.54	16.80	19.38	14.91
	928.96	816.16	742.70	636.43	506.50	470.36
	802.30	685.73	640.01	566.42	426.30	383.85
	189.46	179.04	169.26	141.04	74.18	60.30
	0.00	0.00	0.00	—	—	—
	142.62	140.48	136.78	111.47	74.56	54.75
	50.15	34.36	24.65	16.49	7.70	18.49
	102.26	90.46	88.32	74.55	53.78	41.39
	317.80	241.38	220.99	157.41	134.87	100.94
	126.67	130.44	102.69	70.01	80.20	86.51
	0.00	0.00	0.00	0.00	0.00	0.00
	126.67	130.44	102.69	70.01	80.20	86.51
	28.48	28.94	25.08	13.17	18.09	18.12
	98.11	101.43	77.61	56.84	62.11	68.39
	30.32	31.30	24.04	17.90	19.78	22.89
Key metrics
	279.08	255.26	215.66	161.05	141.68	146.39
	31.70%	33.00%	30.10%	26.00%	29.10%	32.10%
	11.15%	13.10%	10.80%	9.20%	12.80%	15.00%
	—	10.60%	13.00%	—	—	—
	15.90%	7.80%	15.70%	27.20%	7.00%	—
	16.02%	30.70%	36.50%	-8.50%	-9.20%	—
	—	-76.16	-39.30	—	—	—
	—	1.41	1.13	—	—	—
	—	0.54	0.23	—	—	—
	—	504.09	199.68	—	—	—
	—	122.3	107.0	—	—	—
Balance sheet
	—	1,824	1,282	—	—	—
	—	738.34	414.47	—	—	—
	—	30.22	3.85	—	—	—
	—	295.51	277.75	—	—	—
	—	26.66	29.48	—	—	—
	—	24.14	10.53	—	—	—
	—	651.63	667.43	—	—	—
	—	63.20	97.13	—	—	—
	—	275.20	305.39	—	—	—
	—	534.31	203.53	—	—	—
	—	66.02	156.37	—	—	—
	—	468.29	47.16	—	—	—
	—	980.39	882.77	—	—	—
Cash flow
	—	143.10	87.33	—	—	—
	—	-395.99	-99.61	—	—	—
	—	279.26	13.75	—	—	—
	—	219.26	126.63	—	—	—

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24
Income statement
	239.88	210.66	173.02	159.43	182.88	175.62	174.65	165.16	178.72	163.16	159.33	151.55
	6.15	7.21	31.41	3.79	4.21	4.00	4.46	9.29	4.60	7.32	4.34	4.08
	246.04	217.87	204.42	163.23	187.09	179.61	179.11	174.45	183.33	170.48	163.67	155.63
	212.19	196.35	150.29	142.00	156.47	153.28	149.90	146.08	154.83	146.95	141.49	138.76
	53.10	48.45	42.54	37.66	46.77	46.90	41.55	39.90	44.91	42.90	42.99	34.36
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—
	29.21	28.45	25.66	28.01	27.47	28.41	26.50	28.99	28.11	28.77	29.03	26.12
	15.32	14.72	11.86	7.72	8.12	6.25	6.75	6.13	6.39	5.30	7.32	4.14
	28.80	27.70	22.25	22.53	23.46	21.51	21.80	22.69	22.20	21.47	18.12	21.23
	85.75	77.03	47.99	46.09	50.64	50.21	53.30	35.70	36.15	36.18	34.94	35.02
	33.85	21.52	54.13	21.22	30.63	26.34	29.21	28.37	28.50	23.53	22.18	16.87
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—
	33.85	21.52	54.13	21.22	30.63	26.34	29.21	28.37	28.50	23.53	22.18	16.87
	8.53	5.70	10.75	4.73	7.39	6.78	8.15	6.77	6.53	5.35	3.76	3.28
	25.32	15.82	43.38	16.49	23.24	19.56	21.07	21.60	21.96	18.18	18.42	13.59
	7.86	4.88	13.37	5.08	7.12	6.10	6.52	6.69	6.80	5.63	5.70	4.28
Key metrics
	77.97	63.94	88.24	51.47	62.21	54.10	57.76	57.19	57.09	50.30	47.62	42.24
	32.50%	30.40%	51.00%	32.30%	34.00%	30.80%	33.10%	34.60%	31.90%	30.80%	29.90%	27.90%
	10.60%	7.50%	25.10%	10.30%	12.70%	11.10%	12.10%	13.10%	12.30%	11.10%	11.60%	9.00%
	3.10%	—	4.20%	—	3.50%	—	3.70%	—	—	—	—	—
	31.20%	20.00%	-0.90%	-3.50%	2.30%	7.60%	9.60%	9.00%	—	—	—	—
	9.00%	-19.10%	105.90%	-23.70%	5.80%	7.60%	14.40%	58.90%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22
Income statement
	782.99	690.95	681.70	590.02	464.08	454.89
	48.56	43.41	25.67	16.80	19.41	14.93
	831.56	734.36	707.36	606.82	483.49	469.82
	700.83	602.04	597.76	534.87	401.30	380.22
	181.75	173.87	169.26	141.04	74.18	60.30
	0.00	0.00	0.00	—	—	—
	111.33	109.55	112.37	97.57	65.63	53.33
	49.62	33.94	24.57	16.47	7.68	18.49
	101.28	89.76	88.16	74.55	53.78	41.39
	256.86	194.93	203.41	144.31	123.87	98.72
	130.72	132.32	109.60	71.94	82.19	89.60
	0.00	0.00	0.00	—	—	—
	130.72	132.32	109.60	71.94	82.19	89.60
	29.71	29.65	26.79	13.38	18.68	18.90
	101.01	102.67	82.81	58.56	63.51	70.70
	31.19	31.69	25.65	18.45	20.23	23.66
Key metrics
	281.62	256.02	222.33	162.96	143.65	149.48
	35.97%	37.10%	32.60%	27.60%	31.00%	32.90%
	12.90%	14.90%	12.10%	9.90%	13.70%	15.50%
	—	10.70%	13.60%	—	—	—
	12.13%	1.40%	15.50%	27.10%	2.00%	—
	18.18%	24.00%	41.40%	-7.80%	-10.20%	—
	—	-83.39	-36.32	—	—	—
	—	1.31	1.08	—	—	—
	—	0.54	0.23	—	—	—
	—	506.09	198.30	—	—	—
	—	146.4	117.1	—	—	—
Balance sheet
	—	1,818	1,283	—	—	—
	—	744.16	419.16	—	—	—
	—	25.05	3.32	—	—	—
	—	308.27	283.22	—	—	—
	—	25.66	29.48	—	—	—
	—	23.41	10.32	—	—	—
	—	648.32	665.57	—	—	—
	—	56.74	93.95	—	—	—
	—	263.81	299.23	—	—	—
	—	531.14	201.62	—	—	—
	—	65.57	156.14	—	—	—
	—	465.57	45.48	—	—	—
	—	991.91	893.30	—	—	—
Cash flow
	—	134.11	89.38	—	—	—
	—	-390.80	-101.83	—	—	—
	—	278.42	13.90	—	—	—
	—	217.50	125.70	—	—	—

Compounded growth

Standalone

Sales CAGR 3Y: +14.19%
Sales CAGR 5Y: —
Profit CAGR 3Y: +17.36%
Profit CAGR 5Y: —
Sales YoY (TTM): +12.13%
Profit YoY (TTM): +18.18%

Consolidated

Sales CAGR 3Y: +16.63%
Sales CAGR 5Y: —
Profit CAGR 3Y: +17.76%
Profit CAGR 5Y: —
Sales YoY (TTM): +15.90%
Profit YoY (TTM): +16.02%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 27.11%

Quarter	September 2026	June 2026
Promoter %	27.11%	27.11%

Holder	Type	Holding	Previous	Change
RAJENDRA KHIVRAJ MUTHA	Promoter	24.75%	24.75%	0.00%
PHI CAPITAL TRUST - PHI CAPITAL GROWTH FUND - I	Public	15.37%	15.37%	0.00%
TATA MUTUAL FUND - TATA SMALL CAP FUND	Public	8.04%	8.04%	0.00%
KRSNA DIAGNOSTICS (MUMBAI) PRIVATE LIMITED	Promoter Group	2.36%	2.36%	0.00%
AMICORP CAPITAL (MAURITIUS) LIMITED	Public	2.18%	2.18%	0.00%
HDFC LIFE INSURANCE COMPANY LIMITED	Public	2.04%	2.05%	-0.01%
BANDHAN SMALL CAP FUND	Public	1.98%	1.98%	0.00%
MEDIMAZE SOLUTIONS PRIVATE LIMITED	Public	1.03%	1.03%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Dr. Lal Pathlabs Limited	34,056	2,028.95	57.92	25.70%	+16.71% TTM	+8.93% TTM	+28.73%
Vijaya Diagnostic Centre Limited	14,676	1,424.85	72.05	19.20%	+24.48% TTM	+33.96% TTM	+39.02%
Metropolis Healthcare Limited	12,075	582.05	53.57	15.70%	+19.84% TTM	+41.90% TTM	+14.58%
Thyrocare Technologies Limited	7,883	495.25	55.01	33.60%	+21.99% TTM	+13.16% TTM	+9.41%
Nephrocare Health Services Limited	6,242	620.75	48.72	13.70%	—	—	—
SURAKSHA DIAGNOSTIC LIMITED	1,735	333.10	49.46	14.70%	+23.32% TTM	+7.94% TTM	+2.54%
Krsnaa Diagnostics Limited	1,566	482.90	15.97	10.60%	+15.90% TTM	+16.02% TTM	-37.25%
3B BlackBio Dx Limited	1,142	1,330.25	20.29	22.60%	+54.30% TTM	+14.75% TTM	-1.52%
HEALTH X PLATFORM LIMITED	863	271.20	-33.11	—	+28.85% TTM	+82.45% TTM	-8.73%
ONE GLOBAL SERVICE PROVIDER LIMITED S	861	440.70	11.65	65.70%	+161.55% TTM	+178.28% TTM	+21.17%
Gaudium IVF and Women Health Limited	779	107.05	—	23.10%	—	—	—
Aspira Pathlab & Diagnostics Limited S	144	140.35	-318.98	2.90%	+14.50% TTM	-117.58% TTM	+132.68%
Choksi Laboratories Ltd. S	142	203.90	65.77	12.30%	+10.74% TTM	+44.00% TTM	+38.05%
STAR IMAGING AND PATH LAB LIMITED	120	68.90	—	22.60%	—	—	-51.78%
MODERN DIAGNOSTIC & RESEARCH CENTRE LIMITED S	86	57.00	—	11.20%	—	—	—
Sharma East India Hospitals And Res S	34	87.05	24.11	14.20%	+14.13% TTM	-9.85% TTM	-38.28%
BANDARAM PHARMA PACKTECH LIMITED	34	19.03	25.81	4.70%	+114.59% TTM	+454.17% TTM	-22.14%
N.G.Industries Ltd. S	34	100.00	17.39	6.30%	+2.18% TTM	-74.06% TTM	-23.28%
Deccan Health Care Limited	29	12.00	11.40	3.20%	-0.37% TTM	+145.63% TTM	-29.41%
Chennai Meenakshi Multispeciality Hospital Ltd. S	27	36.78	-32.26	-2.80%	+0.08% TTM	+6.59% TTM	-29.27%
SAMSRITA LABS LIMITED	27	11.93	-3.33	-73.40%	—	—	-43.35%
Tejnaksh Healthcare Limited	26	12.83	21.19	5.90%	-12.97% TTM	-33.15% TTM	-27.02%
Transgene Biotek Ltd.	17	2.57	-12.11	-0.50%	-14.81% TTM	-23.85% TTM	-28.21%
Dolphin Medical Services Ltd. S	11	7.11	59.25	0.60%	-1.25% TTM	+700.00% TTM	+246.83%
Looks Health Services Limited S	11	10.08	504.00	0.20%	-41.89% TTM	-57.14% TTM	+101.20%

Filings & corporate actions

Recent announcements

Intimation of Change in Corporate office of Registrar and Sahre Trasnfer Agent of the Company w.e.f. 1st December 2026.3 Nov 2026 · Company Update / General
Audio recording of conference call for the quarter and half year ended September 30, 20263 Nov 2026 · Company Update / Analyst / Investor Meet
Submission of Certificate obtained from Statutory Auditors in terms of Regulation 169(5) of the SEBI ICDR Regulations, 20183 Nov 2026 · Company Update / General
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 - Krsnaa Diagnostics secures 15 year Cash based PPP project from Municipal corporation of Delhi for Advanced CT Scan and ....3 Nov 2026 · Company Update / General
Newspaper Publication pertaining to Unaudited (Standalone and Consolidated) Financial Results for the Quarter and Half Year ended September 30, 20263 Nov 2026 · Company Update / Newspaper Publication
Investor Presentation for the Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Half year ended September 30, 20262 Nov 2026 · Company Update / Investor Presentation
Press Release - Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Half year ended September 30, 20262 Nov 2026 · Company Update / Press Release / Media Release
Financial Results for Quarter and Half Year ended September 30, 20262 Nov 2026 · Result / Financial Results
Outcome of Board Meeting for Q2 FY 2026-272 Nov 2026 · Board Meeting / Outcome of Board Meeting
Outcome of Board Meeting for Q2 FY 2026-272 Nov 2026 · Board Meeting / Outcome of Board Meeting
Investor Call Updates - Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201527 Oct 2026 · Company Update / Analyst / Investor Meet
Krsnaa Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2026 ,inter alia, to consider and approve the Unaudited Financial ....26 Oct 2026 · Board Meeting / Board Meeting
Press Release on Strategic AI Collaboration with AZMed22 Oct 2026 · Company Update / Press Release / Media Release
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Krsna Diagnostics (Mumbai) Pvt Ltd & PAC16 Oct 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Clarification on Allotment of fully Convertible Warrants on a Preferential Basis14 Oct 2026 · Company Update / General
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 - Allotment of Fully Convertible Warrants13 Oct 2026 · Company Update / Allotment of Equity Shares
Intimation of the In-Principle Approval Letter from BSE for issue of 16,21,000 Convertible Warrants to Promoter and Promoter Group of the Company9 Oct 2026 · Company Update / General
Intimation of receipt of In-Principle Approval received for issue of Warrants8 Oct 2026 · Company Update / General
Intimation of receipt of In-Principle Approval received for issue of 16,21,000 warrants convertible into 16,21,000 Equity Shares8 Oct 2026 · Company Update / General
Compliance Certificate under Reg. 74(5) of SEBI (DP) Regulations, 20186 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Submission of revised Voting results.30 Sep 2026 · AGM/EGM / AGM
Intimation for Change in Statutory Auditors of the Company30 Sep 2026 · Company Update / General
Scrutinizer''s Report and Voting Results of 16th Annual General Meeting of the Company30 Sep 2026 · AGM/EGM / AGM
Disclosure under Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201528 Sep 2026 · Company Update / General
Proceedings of 16th Annual General Meeting of the Company.28 Sep 2026 · AGM/EGM / AGM
Intimation of closure of Trading Window under SEBI (Prohibition of Insider Trading) Regulations, 201519 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Krsnaa Diagnostics Limited has intimated the stock exchange regarding the voting results as the outcome of the postal ballot dated September 17, 2026.18 Sep 2026 · AGM/EGM / Postal Ballot
Intimation for signing of Agreement with the Authority16 Sep 2026 · Company Update / General
Intimation - Regulation 36(1)(B) of the SEBI Listing Regulations11 Sep 2026 · Company Update / General
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations , 20159 Sep 2026 · Company Update / General
Newspaper Publication for the Notice convening 16th Annual General Meeting of the Company6 Sep 2026 · Company Update / Newspaper Publication
Please find the attached Business Responsibility and Sustainability Report of the Company for the financial year 2025-265 Sep 2026 · Others / Business Responsibility and Sustainability Reporting (BRSR)
Please find attached the Annual Report of Krsnaa Diagnostics Limited for the FY 2025-26.5 Sep 2026 · Others / Reg. 34 (1) Annual Report
Please find the attached Notice of 16th AGM of the Company scheduled to be held on Monday, September 28, 2026 at 11:00 Hrs. (IST) at the registered office of the Company5 Sep 2026 · AGM/EGM / AGM
Newspaper Publication relating to 16th Annual General Meeting of the Company2 Sep 2026 · Company Update / Newspaper Publication
Newspaper Publication for Issue of Corrigendum with respect to Postal Ballot29 Aug 2026 · Company Update / Newspaper Publication
Corrigendum to the Notice of Postal Ballot28 Aug 2026 · AGM/EGM / Postal Ballot
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 201526 Aug 2026 · Company Update / General
Announcement under Regulation 30 of SEBI (LODR) Regulations, 201520 Aug 2026 · Company Update / General
Transcript of Earnings Call for quarter ended June 30, 202619 Aug 2026 · Company Update / Earnings Call Transcript

Corporate actions

Purpose	Ex date	Record date	Payment date
Final Dividend - Rs. - 2.0000	18 Sep 2026	18 Sep 2026	—
Final Dividend - Rs. - 2.7500	12 Sep 2025	12 Sep 2025	—
Final Dividend - Rs. - 2.5000	13 Sep 2024	13 Sep 2024	—

Board meetings

2 Nov 2026 Board Meeting - Financial Results
13 Aug 2026 Board Meeting - Financial Results